ReviewClinical journal of the American Society of Nephrology : CJASN2026
Ultra-Processed Foods and Food Additives in CKD: Unveiling Hidden Risks and Advocating Smarter Food Choices.
Review in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Review
- Ultra-Processed Foods and the Cardiovascular-Kidney-Metabolic Continuum: Integrating Epidemiological, Multi-Omics, and Translational Evidence.Nutrients · 2026Review
- Dietary Transitions and the Rising Global Burden of Chronic Kidney Disease: Insights from Nutritional Epidemiology.Nutrients · 2026Review
- Association of ultra-processed food consumption with all-cause and cause-specific mortality: population-based cohort study.Frontiers in nutrition · 2026Article
- Real-World Snapshot of Dietary Patterns in Subjects Living with Chronic Kidney Disease.Nutrients · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The term ultra-processed food (UPF) was developed almost two decades ago to define foods which have undergone sophisticated industrial processing. Many of these foods contain added sugars, unhealthy fats, salt, and food additives designed to enhance palatability, extend shelf life, and drive high sales. Owing to these convenient characteristics, the sales and consumption of UPF have consistently increased, with the tendency to replace minimally processed foods in the diet. This shift has led to a decrease in dietary quality and to an increase in the consumption of sugars, unhealthy fats, salt, and food additives, the latter raising concerns about potential toxicity. Therefore, UPF consumption has been associated with increased risk of developing noncommunicable diseases, including CKD, and may have an effect on kidney health in each CKD stage. Primary caregivers should be aware that UPF increases the risk of developing CKD. Providers of secondary and tertiary care should note that UPF contributes to the development of metabolic derangements such as metabolic acidosis, hyperkalemia, hyperphosphatemia, dyslipidemia, and dysbiosis. This review provides a summary of the main adverse effects of UPFs on general health as well as on kidney health. In addition, it gives practical guidance on how to define and assess UPF intake in research and clinical settings, with proposed strategies on how to address UPF consumption in individuals with CKD stages 3-5, aiming at reducing UPF consumption and increasing intake of minimally processed healthier food.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.